Saturday, July 4, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Intuit’s Valuation Discount Is Tempting — But Lawsuits and a DIY Price War Keep Buyers at Bay

Rodolfo Hanigan by Rodolfo Hanigan
July 4, 2026
in Analysis, Tech & Software, Value & Growth
0
Intuit Stock
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Bargain hunters eyeing Intuit’s beaten-down shares are facing a dilemma that few valuation models can resolve. The stock closed at €239.00 on Friday, down 0.77 percent on the day but up 2.07 percent for the week, after a 55.5 percent rout since January. Yet two parallel narratives are now colliding: one of a company that appears genuinely cheap on paper, and another of a business besieged by legal investigations, an erosion of its core do-it-yourself tax customer base, and a competitive landscape reshaped by artificial intelligence.

The legal overhang crystallized after Intuit admitted in its fiscal third quarter that it had “not had the season we expected” in DIY tax filings. The blunt confession — management said it had “lost on price” — triggered a single-day plunge of roughly 20 percent, from $383.93 to $307.07 on May 20. That drop drew the attention of two prominent U.S. law firms. Bleichmar Fonti & Auld is probing whether the company made false or misleading statements about TurboTax’s pricing strategy, both before and during the 2026 filing season. Kahn Swick & Foti is examining a broader window, from December 2, 2025, to May 20, 2026, focusing on potential negligent or fraudulent conduct by executives. Neither firm has filed a formal lawsuit yet, but the investigations add a layer of uncertainty that keeps many institutional buyers on the sidelines.

The irony is that Intuit now passes nearly every quantitative value test. According to metrics compiled by Simply Wall St, the stock fails only one of six valuation benchmarks, with a price-to-earnings ratio of 15.6 against an estimated fair P/E of 35.7. That disparity — a discount of more than 55 percent — positions Intuit as cheaper than both its sector average and what fundamental models suggest. Trefis offers a more cautious take, noting that a P/E of around 16 still represents a discount to peers, but not enough of one to justify the headwinds in the DIY segment.

Those headwinds are real. While Intuit’s assisted tax filing and small-to-medium business units are each growing at more than 30 percent, the core TurboTax DIY franchise is bleeding market share to low-cost, AI-enabled alternatives. Management has acknowledged that it lost the pricing battle in that segment. Revenue over the trailing twelve months nonetheless rose 15.1 percent, and the operating cash flow margin stands at a robust 37.7 percent. By conventional quality measures, the business remains solid. But past crashes within Intuit’s own stock history counsel caution: since 2020, there have been three comparable drawdowns of 30 percent or more within a single month. The median return over the subsequent twelve months was negative 7 percent, and in only one of those three instances did the stock end higher a year later. Buyers who jumped in early typically suffered a further median decline of 9 percent before the stock bottomed.

Should investors sell immediately? Or is it worth buying Intuit?

On the charts, the technical picture is tense. The close at €239.00 sits 66.19 percent below the 52-week high of €706.80 set on July 30, 2025, and only 7.90 percent above the 52-week low of €221.50 touched on June 22. The 200-day moving average of €428.27 lies 44.19 percent above the current price, underscoring the depth of the downtrend. The relative strength index at 43.3 indicates neither oversold nor overbought conditions, while the annualized 30-day volatility of 52.63 percent signals persistent unease.

Analyst opinion is fractured. Citi reaffirmed a Buy rating in late June. Stifel, however, downgraded the stock from Buy to Hold and slashed its price target from $375 to $275. Goldman Sachs went further, issuing a Sell recommendation in early June that accelerated the selloff. Despite these downgrades, roughly 76 percent of analysts still rate the stock a Buy, though the dissenting voices are growing louder.

For income-oriented investors, the stock’s slide has pushed the dividend yield higher. Intuit pays a quarterly dividend of $1.20 per share, with the ex-dividend date set for July 9. The payout is a rare bright spot in a landscape otherwise dominated by investigations, pricing pressure, and a slow-burning identity crisis. Whether Intuit can win back price-sensitive DIY customers without sacrificing its broader strategy will likely determine if the current valuation discount turns out to be a genuine opportunity — or just another trap in a stock that has punished early buyers before.

Ad

Intuit Stock: Buy or Sell?! New Intuit Analysis from July 4 delivers the answer:

The latest Intuit figures speak for themselves: Urgent action needed for Intuit investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 4.

Intuit: Buy or sell? Read more here...

Tags: Intuit
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Outlook Therapeutics Stock
Analysis

Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010

July 4, 2026
Mercedes-Benz Stock
Analysis

Mercedes-Benz Stock Mounts Comeback as Labor Dispute Escalates Over Soured Bonus Payments

July 4, 2026
Realbotix Stock
Mergers & Acquisitions

Realbotix Faces a Pivotal Gamble: Nasdaq Listing Hinges on Supply Chain and Shareholder Approval

July 4, 2026
Next Post
Mercedes-Benz Stock

Mercedes-Benz Stock Mounts Comeback as Labor Dispute Escalates Over Soured Bonus Payments

SpaceX Stock

Starbase Static Fire Clears Path for Next Starship Test as SpaceX Stock Hovers at a Crossroads

Outlook Therapeutics Stock

Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010

Recommended

Ford Stock

Ford’s Strategic Pivot Under Investor Scrutiny Ahead of Earnings

5 months ago
Procter & Gamble Stock

Procter & Gamble: A Defensive Haven in Turbulent Markets

10 months ago
Finances (2)

Stifel Analyst Reaffirms Buy Rating and Raises Price Target for Align Technology

2 years ago
Rocket Lab USA Stock

Strategic Expansion and Record Contracts Fuel Rocket Lab’s Momentum

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Intuit’s Valuation Discount Is Tempting — But Lawsuits and a DIY Price War Keep Buyers at Bay

Realbotix Faces a Pivotal Gamble: Nasdaq Listing Hinges on Supply Chain and Shareholder Approval

Lam Research’s Whiplash Week: Record High, Insider Sales, and a $600 Million China Question

ImmunityBio’s 369% Surge Meets 13% Short Interest — A Collision Course in Biotech

Onco-Innovations’ Share-Linked Payment Plan Threatens Dilution Even as Nanosoft Boosts ONC010 Manufacturing

TSMC Wins Approval for $44 Billion Arizona Buildout as AI Boom Powers Pricing Power

Trending

Outlook Therapeutics Stock
Analysis

Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010

by Rodolfo Hanigan
July 4, 2026
0

July is shaping up as a binary-riddled month for the small-cap biopharma. Two weeks after shareholders cast...

SpaceX Stock

Starbase Static Fire Clears Path for Next Starship Test as SpaceX Stock Hovers at a Crossroads

July 4, 2026
Mercedes-Benz Stock

Mercedes-Benz Stock Mounts Comeback as Labor Dispute Escalates Over Soured Bonus Payments

July 4, 2026
Intuit Stock

Intuit’s Valuation Discount Is Tempting — But Lawsuits and a DIY Price War Keep Buyers at Bay

July 4, 2026
Realbotix Stock

Realbotix Faces a Pivotal Gamble: Nasdaq Listing Hinges on Supply Chain and Shareholder Approval

July 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010
  • Starbase Static Fire Clears Path for Next Starship Test as SpaceX Stock Hovers at a Crossroads
  • Mercedes-Benz Stock Mounts Comeback as Labor Dispute Escalates Over Soured Bonus Payments

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com